Dr Philipp Ivanyi
Medical Oncologist
- Hannover Medical School
Germany
Dr Ivanyi is the Assistant Medical Director Hematology, Oncology, Hemostasis, Stem Cell Transplantation (Palliative Care) at the Hanover Medical School. He is also Head of the Clinical Trial Unit for Medical Oncology
Dr Ivanyi also serves as:
His research interests include clinical and experimental Research in Urogenital Cancer, Head and Neck Cancer, Sarcoma, Rare Cancers, Targeted Therapies. He has >80 SCI Publication and has a depth of experience in >50 Clinical Trials Phase I – IV (PI and Country Lead).
AIM, AIO, Apogepha, Astella, Astra Zeneca, Bayer, BMS, ClinSol, Deciphera, Deutsche Gesellschaft für Thoraxchirurgie, DKG-Onkoweb, EISAI, EMD-Serono, EUSA, FoFM, GSK, Id-Institut, Ipsen (Europe), Lilly, MedKom, Metaplan, MedWiss, Merck Serono (Global), MSD, MTE-Academy, New Concept Oncology, Niedersächsische Krebsgesellschaft, Novartis, Onkowissen-tv.de, Pharma Mare, Pfizer, Roche, Schmitz-Communikation, Solution Academy,Stiftung Immunonkologie, StreamedUP!, ThinkWired!, Vivantis and Wilhelm Sander Stiftung.
Programmes developed by Dr Philipp Ivanyi
Interactive e-learning
Module
1
of 3
Patient case reports: from diagnosis to treatment of TRK-fusion positive cancer – Module 1
Assoc. Prof. Caterina Marchio: A lung cancer case
Experts
Dr Philipp Ivanyi, Assoc. Prof. Caterina Marchiò, Prof. David Hong-
Downloadable
Resources -
15 MIN
-
Aug 2022
Interactive e-learning
Module
2
of 3
Patient case reports: from diagnosis to treatment of TRK-fusion positive cancer – Module 2
Prof. David Hong: Lung cancer, sarcoma and GI cancer
Experts
Dr Philipp Ivanyi, Assoc. Prof. Caterina Marchiò, Prof. David Hong-
15 MIN
-
Aug 2022
Interactive e-learning
Module
3
of 3
Patient case reports: from diagnosis to treatment of TRK-fusion positive cancer – Module 3
Dr Philipp Ivanyi: A thyroid cancer case
Experts
Dr Philipp Ivanyi, Assoc. Prof. Caterina Marchiò, Prof. David Hong-
20 MIN
-
Aug 2022
